 Control acute respiratory illness developing world assessment vaccine intervention major bacterial viral causes morbidity death due respiratory infection ALRI developing world amenable vaccines full use measles pertussis diphtheria vaccines programs immediate contribution reduction severe respiratory infection technologies promise vaccines bacterial viral respiratory pathogens suitable infants children countries technologic advances use protein-polysaccharide conjugates endemic serotypes Haemophilus influenzae Streptococcus vaccines new approaches use purified protein components live virus respiratory syncytial virus paramyxovirus vaccines Such vaccines available evaluation countries program development evaluation worldwide deployment vaccines control ALRI